COLUMBIA, Md., March 13 /PRNewswire-FirstCall/ -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 for brain, eye and heart health, is available in the new Berri Australian Fresh Omega-3 for Heart & Mind juice-blend from National Foods, Australia's No. 1 juice company. National Foods is the largest citrus and fruit processor in Australia, packaging approximately 50 percent of all fruit juice beverages sold in the country. Sold in major retailers across Australia and available in extra pulpy orange flavor with DHA omega-3 for heart and mind, Berri Australian Fresh Omega-3 for Heart & Mind juice-blend provides 50mg per serving of life'sDHA.
"Berri Australian Fresh Omega-3 for Heart & Mind juice-blend marks our second product with National Foods, joining Pura(R) Kids with life'sDHA," said Joe Buron, vice president of marketing and sales for Martek. "We're pleased to be working with one of Australia's largest food companies through their Pura and Berri brands to offer a safe, contaminant-free alternative for Australian consumers to get the important health benefits of DHA."
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Several recent scientific reviews have noted the importance of DHA omega-3 in proper brain and eye development and function, and there are clinical studies underway to evaluate its role in decreasing the prevalence of certain neurological disorders.
Fish are often thought to be the only source of DHA omega-3. However, life'sDHA offers a safe, vegetarian form of DHA that contains no oceanic pollutants and toxins. Fish are rich sources of DHA because they eat microalgae; life'sDHA is derived from microalgae and produced in an FDA- inspected facility from start to finish using a sustainable source that does not deplete ocean resources. life'sDHA is found in numerous foods, beverages and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is available in more than 90 percent of the formulas on the U.S. market.
In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to maximize the availability of life'sDHA in food and beverages.
National Foods is a wholly owned subsidiary of Kirin Holdings Company, Limited -- Incorporated in Japan. It is one of Australia's largest food companies, with core activities in milk, fresh dairy foods, juice and specialty cheese. National Foods' Pura Milk is the country's number one milk brand. Additionally, National Foods is the largest citrus and fruit processor in Australia, packaging approximately 50 percent of all fruit juice beverages sold nationally. For more information on National Foods, visit http://www.natfoods.com.au .
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA, a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com. For a complete list of product, visit http://www.lifesdha.com.
Sections of this release contain forward-looking statements. These
statements are based upon numerous assumptions which Martek cannot control
and involve risks and uncertainties that could cause actual results to
differ. These statements should be understood in light of the risk factors
set forth in the company's filings with the Securities and Exchange
Commission, including, but not limited to, the company's Form 10-K for the
fiscal year ended October 31, 2007 and other filed reports on Form 10-K,
Form 10-K/A, Form 10-Q and Form 8-K.
|SOURCE Martek Biosciences Corporation|
Copyright©2008 PR Newswire.
All rights reserved